可溶性肿瘤坏死因子受体,soluble tumor necrosis factor receptor
1)soluble tumor necrosis factor receptor可溶性肿瘤坏死因子受体
1.Starting at day 1,three groups of animals each received local injections of soluble interleukin-1 receptorⅡ(sIL-1-RⅡ),soluble tumor necrosis factor receptor Ⅰ(sTNF-RⅠ) and their combinations.方法选取64只雄性SD大鼠,从加力第1天起在大鼠牙齿局部分别注射重组人类可溶性白细胞介素-1受体Ⅱ(sIL-1-RⅡ)、可溶性肿瘤坏死因子受体Ⅰ(sTNF-RⅠ)、两者混合物,测量磨牙移动距离,用苏木精-伊红(HE)染色观察被移动磨牙牙周组织形态学变化,并应用抗酒石酸盐酸性磷酸酶(TRAP)组织化学染色对破骨细胞和破牙骨质细胞的数量及分布的时相性改变进行分析。
2.Method:Levels of the plasma anti-inflammatory mediatorsoluble tumor necrosis factor receptor 55 and 75(sTNF-R55 and sTNF-R75) ,and inflammatory mediator tumor necrosis factor α(TNF-α) were analyzed in 62 patients with AECOPD and 30 healthy volunteers on admission and the seve.方法:检测62例COPD急性加重期患者接受β-内酰胺类或喹诺酮类抗菌药物及平喘祛痰治疗及30例健康志愿者入院第1天和治疗第7天血浆中的肿瘤坏死因子α(TNF-α)和可溶性肿瘤坏死因子受体55、75(sTNF-R55、sTNF-R75)的水平及其肺功能(FEV1,FEV1%pre,FEV1/FVC等)。
3.Objective To investigate the expression ofsoluble tumor necrosis factor receptor (sTNFR), carcinoembtyonic(CEA) and neuron-specific enolase(NSE) in lung cancer patients and study its clinical value in such cases.目的探讨可溶性肿瘤坏死因子受体(sTNFR)在肺癌患者血清中的表达水平及联合检测sTN-FR、癌胚抗原(CEA)和神经元特异性烯醇化酶(NSE)对肺癌的临床应用价值。
英文短句/例句
1.The Relationship between Interleukin-10、 Interleukin-18 、Soluble Tumor Necrosis Factor Receptor and Hepatitis B-Associated Chronic Liver;可溶性肿瘤坏死因子受体、白介素-10及白介素-18与慢性乙型病毒性肝病的关系
2.The Study of the Significance of Plasma Soluble TNF Receptors for Neonates with Hypoxic Ischemic Encephalopathy;新生儿缺氧缺血性脑病血浆可溶性肿瘤坏死因子受体的水平变化及意义探讨
3.Expression of sTNFR_(55) and Pathogenesis in 2-Type Diabetic Lean Group;可溶性肿瘤坏死因子受体55在2型糖尿病消瘦型人群表达及发病机理研究
4.Effect of X ray on shedding of soluble tumor necrosis factor receptor-p75 in human colorectal cancer cells Lovo in vitro可溶性肿瘤坏死因子受体p75检测在X线照射大肠癌细胞株Lovo细胞中的意义
5.Effect of X-ray exposure on soluble tumor necrosis factor receptor-p75 release in hepatocellular carcinoma HepG2 cells in vitro检测X线照射肝癌细胞株HepG2可溶性肿瘤坏死因子受体-p75的临床意义
6.Detection and Clinical Significance of Serum Tumor Necrosis Factor-α and Soluble Tumor Necrosis Factor Receptors Levels in Patients with Atopic Dermatitis特应性皮炎肿瘤坏死因子及可溶性受体检测
7.The Abnormality of Tumor Necrosis Factor and Its Soluble Receptors in Systemic Lupus Erythematosus and Its Significance;系统性红斑狼疮肿瘤坏死因子及其可溶性受体的异常及意义
8.Investigation of Soluble TNF-α Receptor to Silica Induced Pulmonary Fibrosis in Rats;肿瘤坏死因子-α可溶性受体对矽肺纤维化的干预研究
9.Study on the Mechanism of Insulin Resistance Induced by Tumor Necrosis Factor-α and Soluble Receptor and Gene Polymorphism in Gestational Diabetes Mellitus;肿瘤坏死因子α、可溶性受体及其基因多态性在妊娠期糖尿病发病机制作用的研究
10.The Experimental Study on Gene Therapy of A New Biologic Immunosupression Agent-Soluble Tumor Necrosis Factor-a Receptor(sTNF-RI)in Transplantation;一种生物型免疫抑制剂——可溶性肿瘤坏死因子α受体I基因治疗移植的实验研究
11.The Relationship between Tumor Necrosis Factor-α, Its Soluble Receptors and Insulin Resistance in the Patients with Gestational Diabetes Mellitus;肿瘤坏死因子-α及其可溶性受体与妊娠期糖尿病胰岛素抵抗的关系研究
12.Research progress of tumor necrosis factor-α and its receptor in bone resorption of inflammatory diseases肿瘤坏死因子-α及其受体与炎症性骨破坏
13.Investigation of Expression of Tumour Necrosis Factor and Its Receptor in Yin-deficiency Syndrome of Cancer;恶性肿瘤阴虚证肿瘤坏死因子及其受体表达的实验研究
14.Expression of soluble CD40 ligand and tumor necrosis factor-α in malignant lymphoma patients恶性淋巴瘤血清中可溶性CD40配体与肿瘤坏死因子α表达的临床意义
15.Clinical significance of human soluble tumor necrosis factor-related apoptosis inducing ligand in patients with primary biliary cirrhosis可溶性肿瘤坏死因子相关凋亡诱导配体在原发性胆汁性肝硬化患者血清中的表达及意义
16.Expression, Purification and Biological Activity Analysis of Recombinant Human Soluble TRAIL in Pichia Pastoris;重组人可溶性肿瘤坏死因子相关凋亡诱导配体在毕赤酵母中的表达、纯化及生物活性研究
17.Association of Tumor Necrosis Factor Receptor (TNFR Ⅱ) Polymorphism with Susceptibility to Coronary Heart Disease;肿瘤坏死因子受体Ⅱ及其基因多态性与冠心病易感性关系的研究
18.Association of the tumor necrosis factor receptor gene polymorphisms with the genetic susceptibility to dilated cardiomyopathy肿瘤坏死因子受体基因多态性与扩张型心肌病遗传易感性的关系
相关短句/例句
soluble tumor necrosis factor receptor (sTNFR)可溶性肿瘤坏死因子受体
1.Objective: To explore the significance of the serum soluble tumor necrosis factor receptor (sTNFR).目的探讨食管癌患者的血清可溶性肿瘤坏死因子受体 (sTNF RI、sTNF RII)水平及其临床意义。
3)Soluble tumor necrosis factor receptor 1(sTNFR1)可溶性肿瘤坏死因子受体1(sTNFR1)
4)Soluble tumor necrosis factor receptorⅠ可溶性肿瘤坏死因子I型受体
5)Soluble tumor necrosis factor receptor 1可溶性肿瘤坏死因子受体1
6)human sTNFR1人可溶性肿瘤坏死因子受体1
1.Construction of eukaryotic vector ofhuman sTNFR1;人可溶性肿瘤坏死因子受体1基因真核表达载体的构建
2.Objective To construct an eukaryotic expression vector ofhuman sTNFR1 and to investigate its inhibitory effects to the bioactivity of TNF-α.目的构建人可溶性肿瘤坏死因子受体1基因(sTNFR1)的真核表达载体,研究sTNFR1对TNF-α细胞毒效应的抑制作用。
延伸阅读
肿瘤坏死因子分子式：CAS号：性质：又称恶液质素(cachectin)，淋巴毒素(lymphotoxin；LT)。注射卡介苗短小棒状杆菌和酵母多糖等制剂，再以内毒素攻击在小鼠、大鼠和兔等多种动物的血清中出现的一种能引起肿瘤出血性坏死的活性成分。含有唾液酸和半乳糖胺的一种糖蛋白，分子量约150 000。根据其产生来源和结构不同，可分为TNF-α和TNF-β两类，前者有单核-巨噬细胞产生，后者有活化T细胞产生，现已有基因重组技术制备。两类TNF的基本生物活性相似，除具有杀伤肿瘤细胞外，还有免疫调节，参与发热和炎症的发生。大剂量TNF-α可引起恶液质，医疗上可单独或白细胞介素2联合用于治疗肿瘤。
